Christopher Powala
Direktor/Vorstandsmitglied bei NFlection Therapeutics, Inc.
Profil
Christopher V.
Powala was the founder of Vicept Therapeutics, Inc. (founded in 2009) where he held the title of Chief Operating Officer from 2009 to 2011.
He is also the founder of Aclaris Therapeutics, Inc. (founded in 2012) where he held the title of Chief Regulatory & Development Officer from 2018 to 2019.
Mr. Powala's current job is as a Director at NFlection Therapeutics, Inc. (job start in 2021).
His former jobs include being the VP-Drug Development & Regulatory Affairs at CollaGenex Pharmaceuticals, Inc. (job start in 1993, job end in 2008), the VP-Clinical Operations & Global Regulatory Affairs at Vital Therapies, Inc. (job start in 2008, job end in 2009), and a Principal at Wyeth Laboratories, Inc. (job start in 1985, job end in 1993).
Mr. Powala's education history includes an undergraduate degree from The State University of New York.
Aktive Positionen von Christopher Powala
| Unternehmen | Position | Beginn |
|---|---|---|
NFlection Therapeutics, Inc.
 NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher Powala
| Unternehmen | Position | Ende |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Gründer | 03.06.2019 |
Vicept Therapeutics, Inc.
 Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Gründer | 01.07.2011 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.05.2009 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | General Counsel | 01.01.2008 |
| Wyeth Laboratories, Inc. | Corporate Officer/Principal | 01.01.1993 |
Ausbildung von Christopher Powala
| The State University of New York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Health Technology |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
| Wyeth Laboratories, Inc. | |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Health Technology |
